Wednesday
24 Apr 2024
Home
快讯
By
我国与Covax辉瑞阿斯利康签协议确保40%人口获疫苗供应 并与科兴生物(Sinovac)、康希诺生物(CanSino)及Gamaleya洽商将疫苗供应增至80%人口
Most Read
Just In
Print
Text Size
Share